Posted inBusiness Strategy
Australian Stock Market Today
The firm is involved within the discovery and development of novel antibody-based most cancers immunotherapies. Most advanced NEObody product candidate, ADG106, is a totally human ligand-blocking agonistic anti-CD137 mAb presently…